Other News To Note
MAP Pharmaceuticals Inc., of Mountain View, Calif., said it plans to resubmit its new drug application for Levadex (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults in the late third quarter/early fourth quarter.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter